Cancer Prevention Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

Published Online First on March 19, 2008
[Cancer Prevention Research, 10.1158/1940-6207.CAPR-08-0029]
This Article
Right arrow Full Text (Online First [PDF])
Right arrow Related Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Issa, J.-P.
PubMed
Right arrow Articles by Issa, J.-P.
Related Collections
Right arrow Perspective
Right arrowKey Article

Perspective

Cancer Prevention: Epigenetics Steps Up to the Plate

Jean-Pierre Issa

Author's Affiliation: Department of Leukemia and Epigenetics Center, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

Requests for reprints: Jean-Pierre Issa, Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 428, Houston, TX, 77030. Phone: 713-745-2260; Fax: 713-796-0318; E-mail: jpissa{at}mdanderson.org.

Abstract

The fields both of cancer prevention and epigenetics have matured to a point where their intersection deserves sustained attention. There now is strong evidence for an epigenetic component of early neoplasia, and data on the cancer preventive properties of epigenetic modulation are emerging. With preclinical proof of principle at hand, the challenge is to translate these epigenetic findings into testable clinical hypotheses.


Key Article

Long-term Epigenetic Therapy with Oral Zebularine Has Minimal Side Effects and Prevents Intestinal Tumors in Mice
Christine B. Yoo, Jody C. Chuang, Hyang-Min Byun, Gerda Egger, Allen S. Yang, Louis Dubeau, Tiffany Long, Peter W. Laird, Victor E. Marquez, and Peter A. Jones
Cancer Prevention Research 2008 0: 1940-6207.CAPR-07-0008v1. [Abstract]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2008 by the American Association for Cancer Research.